Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
Roshini Claire Anthony, 20 hours ago

The presence of pulmonary arterial hypertension (PAH) in individuals with systemic sclerosis is associated with an increased mortality risk, a study from Singapore showed.

23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
09 Jan 2020
Acute ischaemic stroke patients who are current or recent smokers are at greater odds of having unfavourable functional outcomes 3 months after the index event, a study has found.

Pomegranate juice may confer memory benefits in adults

10 Jan 2020

Drinking pomegranate juice daily appears to have memory effects in middle-aged and older adults by stabilizing the capacity to absorb visual information over a 12-month period, suggests a study.

“Antioxidant nutrients such as the polyphenols in pomegranate juice may prevent neuronal damage from the free radicals produced during normal metabolism,” the investigators said.

This 12-month, randomized, double-blind, placebo-controlled trial included 261 participants aged 50–75 years, who were randomly assigned to consume either pomegranate juice (n=126; 236.5 mL/day) or a placebo drink (n=135; 236.5 mL, matched constituents of pomegranate juice except for pomegranate polyphenols).

The investigators used a mixed-effects general linear model to assess (at 6 and 12 months) and analyse memory measures (Brief Visuospatial Memory Test-Revised [BVMT-R] and Buschke Selective Reminding Test [SRT]).

Twenty-eight participants in the pomegranate juice group and 33 in the placebo group dropped out of the trial prior to study completion. No significant difference was observed in baseline variable in the 98 pomegranate juice and 102 placebo group participants who completed the study.

There was a statistically significant group-by-time interaction for BVMT-R Learning (F[2, 257], 5.90; p=0.003; between-group effect size [ES], 0.45). No significant change was seen within the pomegranate juice group (ES, 0.15), whereas a significant decline was observed in the placebo group (ES, –0.35).

No significant between-group difference was noted in changes in the other BVMT-R scores as well as the SRT measures.

“Previous research in animals and a short-term clinical trial in middle-aged and older adults support the potential memory benefits of pomegranate juice,” the investigators said. “[H]owever, the long-term effects of pomegranate juice consumption on cognition have not been studied.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
Roshini Claire Anthony, 20 hours ago

The presence of pulmonary arterial hypertension (PAH) in individuals with systemic sclerosis is associated with an increased mortality risk, a study from Singapore showed.

23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
09 Jan 2020
Acute ischaemic stroke patients who are current or recent smokers are at greater odds of having unfavourable functional outcomes 3 months after the index event, a study has found.